Navigation Links
Pharmacyclics Reports Second Quarter 2014 Results
Date:7/31/2014

Phase III study of IMBRUVICA in combination with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) in patients with newly diagnosed non-GCB subtype of DLBCL was initiated in the third quarter of 2013. This is a randomized, multi-center, double-blinded, controlled trial of IMBRUVICA plus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) versus R-CHOP in patients with newly diagnosed non-GCB subtype DLBCL. The primary endpoint of the study is to demonstrate a clinically significant improvement in event-free survival when compared to R-CHOP. The enrollment target of this global study is 800 patients.

Follicular Lymphoma (FL)

  • PCYC 1125: Phase II multicenter, open-label, study of IMBRUVICA, in combination with Rituximab in previously untreated subjects with follicular lymphoma was initiated in the fourth quarter of 2013. The primary endpoint of this study is overall response rate. The enrollment target of this study is 80 patients.
  • DAWN (FLR2002): Phase II study of IMBRUVICA in patients with R/R FL was initiated in the second quarter of 2013. This is a multi-center, open-label, single-arm, global trial of IMBRUVICA in patients with chemoimmunotherapy-resistant FL, whose disease has relapsed from at least two prior lines of therapy, including at least one rituximab combination chemotherapy regimen. The primary endpoint of this study is overall response rate. This study completed enrollment of 111 patients worldwide in Q2 of 2014. A data read out is anticipated in the second half of 2015.
  • SELENE (FLR3001): Phase III study of IMBRUVICA in patients with R/R indolent Non-Hodgkin's Lymphoma (iNHL) was initiated in the first quarter of 2014. This is a randomized, multi-center, placebo-controlled trial in combination with either BR or R-CHOP in patients with previously treated indolent Non-Hodgkin Lymphoma (iNHL). The primary endpoint of this study is progression free survival.
    '/>"/>

  • SOURCE Pharmacyclics, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

    Related medicine technology :

    1. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014
    2. Pharmacyclics Announces Data Presentations for Ibrutinib in B-Cell Malignancies
    3. WuXi PharmaTech to Partner with Pharmacyclics
    4. Pharmacyclics Reports Third Quarter 2013 Results
    5. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Third Quarter Ended September 30, 2013
    6. Pharmacyclics Reports Second Quarter 2013 Results
    7. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
    8. Pharmacyclics Reports First Quarter 2013 Results
    9. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
    10. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
    11. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/6/2015)... N.J. , July 6, 2015 ... on developing novel therapeutics that target inflammation and ... Bradford , M.D., PhD, as Chief Medical Officer. ... company,s clinical development strategy and programs, which include ... other inflammatory and fibrotic conditions.  Bill is an ...
    (Date:7/6/2015)... July 6, 2015   Cepheid (Nasdaq: CPHD ... for its 2015 second quarter ended June 30, 2015 ... the market. The Company will host a ... July 23, 2015, to discuss the results.  To access ... http://ir.cepheid.com at least 15 minutes before the scheduled ...
    (Date:7/6/2015)... 2015 China Information Technology, Inc. (the "Company" ... integrated cloud-based platform, exchange, and big data solutions in ... Company launched its mobile app for Healthcare One Pass, ... on mobile devices. The Company jointly hosted the launch ... Bureau and Shenzhen News Net.   The mobile ...
    Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4
    (Date:7/6/2015)... ... July 06, 2015 , ... Seedstock today announced Pierre ... address at the 4th Annual Seedstock Sustainable Agriculture Conference – “Innovation and the Small ... , held at the University of California-San Diego, will explore solutions and methodologies that ...
    (Date:7/6/2015)... , ... July 06, 2015 , ... In a split ... how to reduce their risk of having a fracture through the bone health screenings ... Awareness Day. , “We are participating because our residents need this information to remain ...
    (Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is now offering the newly ... is a non-surgical method to dissolve fat cells and is the first of ... deposits under the chin, commonly known as a double chin. Dr. Green participated in ...
    (Date:7/6/2015)... ... , ... Thanks to donations and a generous grant from the GAR Foundation, ... for hospice patients and adult day center participants. , The Music & Memory program ... to their families and volunteers. Music & Memory is a non-profit organization that helps ...
    (Date:7/5/2015)... ... ... Women's Excellence in Wellness, powered by Movestrong announces parent/child fitness classes ... families that want their children to stay active as well as spend time with ... place TUESDAYS at 4:30pm. Questions? Call 248-601-6683. Women’s Excellence in Wellness, powered by ...
    Breaking Medicine News(10 mins):Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:National Bone Health Screening and Awareness Day 2Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4
    ... BEACH, Calif. May 26 Forterus Inc. (Pink Sheets: FTER), ... Inc. in Murrieta, California, said today that an advertisement for ... Network a number of times in May and June.The ad, ... , explains that Forterus offers a safe, caring, ...
    ... creates single-source solution for leading medical destinations, doctors and treatment packages ... ... Patients Beyond Borders, one of the most recognized names in ... high-quality healthcare overseas, has agreed to be a content partner for ...
    ... Veracord™, ( www.veracord.com ), a privately held ... Parasoft® Corporation, a leading provider of automated ... the Parasoft award-winning product offering beyond product ... compliance. Together, Veracord and Parasoft offer clients ...
    ... worldwide leader in bottle-less water purification cooler technology, has launched ... and to support its Pure Water Finance division. , ... ... -- PHSI manufactures and distributes water purification coolers that replace ...
    ... at The Association for Research in Vision and Ophthalmology ARVO ... of Transpalpebral Tonometer Diaton Compared to Goldmann Applanation Tonometer in ... Latina, the inventor of Selective Laser Trabeculoplasty (SLT). , ... ...
    ... will Help People Save More Money into Health Savings Accounts - A Smart ... ... 2009 -- Healthy Rebates, Inc. today announced the launch of My HSA Rewards, ... new program to help save more money for health care. , , ...
    Cached Medicine News:Health News:Medeguide and Patients Beyond Borders Collaborate to Feature Global Healthcare Options Online 2Health News:Veracord and Parasoft Partner to Improve Compliance and Reduce Cost 2Health News:Veracord and Parasoft Partner to Improve Compliance and Reduce Cost 3Health News:PHSI Launches New Websites to Promote Sustainable Eco-Friendly Bottle-less Drinking Water Technology 2Health News:PHSI Launches New Websites to Promote Sustainable Eco-Friendly Bottle-less Drinking Water Technology 3Health News:Thumbs Up at ARVO for Diaton Tonometer - New Through Eyelid Glaucoma Test Clinical Study Presented, Results as Accurate as Gold Standard 2Health News:Thumbs Up at ARVO for Diaton Tonometer - New Through Eyelid Glaucoma Test Clinical Study Presented, Results as Accurate as Gold Standard 3Health News:Healthy Rebates, Inc. Announces the Launch of My HSA Rewards 2
    ... years, Palacos® Bone Cement has clinically ... in cemented arthroplasty. Palacos® is now ... providing an antibiotic loaded bone cement ... stage of a two-stage revision after ...
    Occu-Flo Plugs Offer: , Easy Insertion , A polished, smooth, transparent finish which creates immediate patient comfort and adaptation , High tolerance by patients , No discomfort should removal be ...
    ... One glance at the Parasol Punctal ... patented product which offers several distinct advantages ... ,Easy to Insert. The Parasol's hollow nose ... punctal dilation in most cases. It's easier ...
    Extended Duration absorbable plugs are designed to provide patient comfort for up to 3 months. This long lasting plug is effective and economical for transient dry eye symptoms following surgery. Ext...
    Medicine Products: